Innovent Biologics (IVBXF) Short Interest Ratio & Short Volume → Urgent Nvidia Warning (From Altimetry) (Ad) Free IVBXF Stock Alerts $5.38 +0.47 (+9.57%) (As of 05/2/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartHeadlinesShort InterestStock AnalysisAnalyst ForecastsChartHeadlinesShort Interest Innovent Biologics Short Interest DataCurrent Short Volume3,466,300 sharesPrevious Short Volume3,191,000 sharesChange Vs. Previous Month+8.63%Dollar Volume Sold Short$15.94 millionShort Interest Ratio / Days to Cover990.4Last Record DateApril 15, 2024Today's Trading Volume19,600 sharesAverage Trading Volume203,813 sharesToday's Volume Vs. Average10% Short Selling Innovent Biologics ? Sign up to receive the latest short interest report for Innovent Biologics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatIVBXF Short Interest Over TimeIVBXF Days to Cover Over TimeIVBXF Percentage of Float Shorted Over Time Ad Weiss RatingsFW: 234x GainThis coin is an essential building block for an ongoing financial revolution of massive dimensions. As a big part of this revolution, the big banks of the world must connect to the blockchain.Click here. Innovent Biologics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20243,466,300 shares $15.94 million +8.6%N/A990.4 $4.60 3/31/20243,191,000 shares $15.60 million +1.6%N/A2454.6 $4.89 3/15/20243,140,300 shares $17.21 million -1.7%N/A107.5 $5.48 2/29/20243,193,000 shares $17.37 million +0.1%N/A570.2 $5.44 2/15/20243,189,100 shares $14.80 million +4.4%N/A1328.8 $4.64 1/15/20241,425,700 shares $7.68 million -11.1%N/A1.9 $5.39 Get the Latest News and Ratings for IVBXF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Innovent Biologics and its competitors with MarketBeat's FREE daily newsletter. 12/31/20231,602,800 shares $7.89 million -16.1%N/A7.3 $4.92 12/15/20231,909,700 shares $10.16 million +28.7%N/A187.2 $5.32 11/30/20231,484,300 shares $8.62 million -10.1%N/A1349.4 $5.81 11/15/20231,651,800 shares $9.76 million -36.2%N/A611.8 $5.91 10/31/20232,590,000 shares $15.24 million -23.3%N/A893.1 $5.89 10/15/20233,377,500 shares $16.89 million +1.0%N/A1250.9 $5.00 9/30/20233,343,500 shares $16.72 million -35.2%N/A33435 $5.00 9/15/20235,158,800 shares $22.63 million +1.6%N/A17196 $4.39 8/31/20235,077,800 shares $18.03 million -9.5%N/A990 $3.55 8/15/20235,608,800 shares $19.91 million +0.3%N/A277.7 $3.55 7/31/20235,592,800 shares $21.87 million -2.3%N/A55928 $3.91 7/15/20235,725,300 shares $22.39 million -3.4%N/A1908.4 $3.91 6/30/20235,926,700 shares $23.65 million +3.1%N/A2694 $3.99 6/15/20235,748,000 shares $27.48 million -7.3%N/A11496 $4.78 5/31/20236,202,800 shares $29.40 million -0.6%N/A8861.1 $4.74 5/15/20236,241,300 shares $31.46 million +0.6%N/A12482.6 $5.04 4/30/20236,201,800 shares $29.83 million -3.7%N/A7752.3 $4.81 4/15/20236,436,800 shares $30.38 million -1.0%N/A1129.3 $4.72 3/31/20236,498,300 shares $31.00 million -5.0%N/A3420.2 $4.77 3/15/20236,837,300 shares $32.61 million +10.4%N/A2629.7 $4.77 2/28/20236,192,300 shares $29.54 million -2.9%N/A6880.3 $4.77 2/15/20236,375,300 shares $34.21 million +5.4%N/A3035.9 $5.37 1/31/20236,048,300 shares $32.96 million -0.2%N/A2160.1 $5.45 1/15/20236,061,300 shares $32.55 million -0.8%N/A993.7 $5.37 12/30/20226,111,900 shares $26.19 million +0.3%N/A442.9 $4.29 12/15/20226,091,900 shares $25.83 million -3.4%N/A2343 $4.24 11/30/20226,306,100 shares $24.91 million -10.4%N/A750.7 $3.95 11/15/20227,034,100 shares $30.95 million -1.8%N/A1153.1 $4.40 10/31/20227,160,600 shares $25.42 million +11.5%N/A1256.2 $3.55 10/15/20226,420,100 shares $17.39 million -0.6%N/A12840.2 $2.71 9/30/20226,456,100 shares $24.06 million +7.3%N/A64561 $3.73 9/15/20226,014,600 shares $22.41 million -17.2%N/A20048.7 $3.73 8/31/20227,264,400 shares $29.42 million -4.1%N/A10377.7 $4.05 8/15/20227,577,900 shares $35.39 million +19.3%N/A1353.2 $4.67Could Your Accounts Be Frozen? (Ad)The US Dollar Is "Finished" A deteriorating economy, global instability, and a weakened banking system have pushed the U.S. financial system to the brink, imperiling the value of your savings and investments.Get your Free Wealth Protection Kit IVBXF Short Interest - Frequently Asked Questions What is Innovent Biologics' current short interest? Short interest is the volume of Innovent Biologics shares that have been sold short but have not yet been covered or closed out. As of April 15th, traders have sold 3,466,300 shares of IVBXF short. Learn More on Innovent Biologics' current short interest. What is a good short interest ratio for Innovent Biologics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. IVBXF shares currently have a short interest ratio of 990.0. Learn More on Innovent Biologics's short interest ratio. Is Innovent Biologics' short interest increasing or decreasing? Innovent Biologics saw a increase in short interest during the month of April. As of April 15th, there was short interest totaling 3,466,300 shares, an increase of 8.6% from the previous total of 3,191,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Innovent Biologics stock? Short selling IVBXF is an investing strategy that aims to generate trading profit from Innovent Biologics as its price is falling. IVBXF shares are trading up $0.47 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Innovent Biologics? A short squeeze for Innovent Biologics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of IVBXF, which in turn drives the price of the stock up even further. How often is Innovent Biologics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including IVBXF, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: 180 Life Sciences Short Interest Data 3SBio Short Interest Data Algernon Pharmaceuticals Short Interest Data Alpha Tau Medical Short Interest Data Apollomics Short Interest Data Artelo Biosciences Short Interest Data Ascentage Pharma Group International Short Interest Data Ascletis Pharma Short Interest Data Avacta Group Short Interest Data Awakn Life Sciences Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:IVBXF) was last updated on 5/3/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldThe AI stock to buy right nowStockEarningsFW: 234x GainWeiss RatingsCould Your Accounts Be Frozen?Allegiance GoldUrgent Nvidia WarningAltimetryDollar CancelledLear CapitalRich Dad Poor Dad Author Shocks Millions With 2024 Crash WarningAmerican Hartford Gold GroupForget Bitcoin: This $8 Stock Is the Next Big ThingBehind the Markets